Burkhardt O - Search Results

1

[New antibiotics for treatment of MRSA infections. Comparison of treatment with vancomycin].

Burkhardt O, Derendorf H, Welte T. Burkhardt O, et al. Med Monatsschr Pharm. 2006 Feb;29(2):56-62; quiz 63-4. Med Monatsschr Pharm. 2006. PMID: 16506589 Review. German. No abstract available.

2

[Achieving eradication of MRSA colonization in patients. Therapeutic options].

Burkhardt O, Derendorf H, Welte T. Burkhardt O, et al. Med Monatsschr Pharm. 2006 Jan;29(1):17-21. Med Monatsschr Pharm. 2006. PMID: 16463549 Review. German. No abstract available.

3

Penetration of ertapenem into skeletal muscle and subcutaneous adipose tissue in healthy volunteers measured by in vivo microdialysis.

Burkhardt O, Brunner M, Schmidt S, Grant M, Tang Y, Derendorf H. Burkhardt O, et al. J Antimicrob Chemother. 2006 Sep;58(3):632-6. doi: 10.1093/jac/dkl284. Epub 2006 Jul 12. J Antimicrob Chemother. 2006. PMID: 16840426 Clinical Trial.

4

Ertapenem in critically ill patients with early-onset ventilator-associated pneumonia: pharmacokinetics with special consideration of free-drug concentration.

Burkhardt O, Kumar V, Katterwe D, Majcher-Peszynska J, Drewelow B, Derendorf H, Welte T. Burkhardt O, et al. J Antimicrob Chemother. 2007 Feb;59(2):277-84. doi: 10.1093/jac/dkl485. Epub 2006 Dec 21. J Antimicrob Chemother. 2007. PMID: 17185298

5

Effect of protein binding on the pharmacological activity of highly bound antibiotics.

Schmidt S, Röck K, Sahre M, Burkhardt O, Brunner M, Lobmeyer MT, Derendorf H. Schmidt S, et al. Among authors: burkhardt o. Antimicrob Agents Chemother. 2008 Nov;52(11):3994-4000. doi: 10.1128/AAC.00427-08. Epub 2008 Sep 8. Antimicrob Agents Chemother. 2008. PMID: 18779351 Free PMC article.

6

Clinical pharmacokinetics and pharmacodynamics of tigecycline.

Barbour A, Schmidt S, Ma B, Schiefelbein L, Rand KH, Burkhardt O, Derendorf H. Barbour A, et al. Among authors: burkhardt o. Clin Pharmacokinet. 2009;48(9):575-84. doi: 10.2165/11317100-000000000-00000. Clin Pharmacokinet. 2009. PMID: 19725592 Review.

7

Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) pneumonia: linezolid or vancomycin? - Comparison of pharmacology and clinical efficacy.

Pletz MW, Burkhardt O, Welte T. Pletz MW, et al. Among authors: burkhardt o. Eur J Med Res. 2010 Nov 30;15(12):507-13. doi: 10.1186/2047-783x-15-12-507. Eur J Med Res. 2010. PMID: 21163725 Free PMC article. Review.

8

Effects of enteral feeding on the oral bioavailability of moxifloxacin in healthy volunteers.

Burkhardt O, Stass H, Thuss U, Borner K, Welte T. Burkhardt O, et al. Clin Pharmacokinet. 2005;44(9):969-76. doi: 10.2165/00003088-200544090-00006. Clin Pharmacokinet. 2005. PMID: 16122283 Clinical Trial.

9

Moxifloxacin distribution in the interstitial space of infected decubitus ulcer tissue of patients with spinal cord injury measured by in vivo microdialysis.

Burkhardt O, Derendorf H, Jäger D, Kumar V, Madabushi R, Röhl K, Barth J. Burkhardt O, et al. Scand J Infect Dis. 2006;38(10):904-8. doi: 10.1080/00365540600664076. Scand J Infect Dis. 2006. PMID: 17008236

10

Ertapenem: the new carbapenem 5 years after first FDA licensing for clinical practice.

Burkhardt O, Derendorf H, Welte T. Burkhardt O, et al. Expert Opin Pharmacother. 2007 Feb;8(2):237-56. doi: 10.1517/14656566.8.2.237. Expert Opin Pharmacother. 2007. PMID: 17257093 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

79 results

Search Page

Filters